Skip navigation
Kallik

Members of the pharma community need to make labelling a top priority or face major penalties, as well as suffer inefficiencies in their business.

Labelling content & artwork management leader Kallik’s founder and CEO Neil Gleghorn to present fresh thinking at a major life sciences conference: why now is the time to solve the sector’s content challenges

Tamworth, 9 February, 2015 – Labelling & Artwork management leader Kallik founder and CEO Neil Gleghorn has been invited to deliver a presentation at CSC Life Sciences’ 'Life Sciences Forum: Innovation for Business Growth’ event.

At the major life sciences conference, scheduled for February 11-12 in Malaga, Spain, Gleghorn will present on how the sector can best address the labelling challenges accumulating for players in the industry.

Gleghorn will draw on his extensive knowledge and understanding of the pharma industry’s specific challenges (key to his winning a PharmaVOICE 100 place last year, an award that celebrates the most influential people in the life sciences industry).

Gleghorn will look at typical artwork and labelling practices before outlining the business context: how pharma is battling rising product recalls, to how the medical device field is being forced to respond to latest UDI regulations to how cosmetics firms are tackling new labelling requirements.

This set of circumstances, Gleghorn will argue, means that centralising the creation and management of Labelling and Artwork Management (LAM) needs to be much higher on the C-Suite’s agenda.

For Gleghorn, “The amount of regulation and legislation coming our way has never been higher, forcing the need to have a robust, transparent process in place to deal with this compliance.

Members of the pharma community need to make labelling a top priority or face major penalties, as well as suffer inefficiencies in their business.

Kallik has been at the forefront of dealing with these issues, having over a decade helped firms capture and manage labelling-based content digitally so as to transform the way large national and international brands bring products to market.

Gleghorn’s commitment to that vision has helped the UK firm become a truly global player, working with some of the world’s biggest companies in regulated markets including the pharmaceutical, medical device, cosmetics and chemicals vertical sectors.

Gleghorn is available for interview at the Life Sciences Forum on Wednesday February 11 on the need for robust labelling processes: for further information and for interviews, please contact Sarum.

About Kallik
Kallik is a global provider of Labelling & Artwork Management software solutions (LAM) that simplify complex artwork management, generation and approval challenges for regulated industries: Kallik’s systems help these organisations to reduce the risk of product recall, guarantee product and brand consistency, mitigate risk and reduce costs.

Based on technologies using a structured content-centric approach, Kallik’s solutions leverage and repurpose content to automatically generate artwork. This enables businesses to remove duplication, track content and rapidly change messaging to respond to new market and regulatory challenges.

Formed in 2001, Kallik’s founders and senior management team have a rich heritage in the packaging and labelling industry. Its flagship AMS360™ Automated Artwork Management solution was devised based on this insider knowledge of the sector and today underpins the businesses of companies including Sealed Air, Coloplast, Integra, Mary Kay, VitaHealth and Unilever.

More at www.kallik.com, or follow us on Twitter @KallikAMS

PR Contact
Carina Birt
PR for Kallik
carina@sarumpr.com
+44 1722 322916

This press release was distributed by ResponseSource Press Release Wire on behalf of Sarum PR in the following categories: Business & Finance, Medical & Pharmaceutical, Manufacturing, Engineering & Energy, Computing & Telecoms, for more information visit http://pressreleasewire.responsesource.com/about.